about
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's diseaseGenome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociEfficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to dateInflammatory bowel disease in australasian children and adolescentsMeta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand caucasian population: a case-control study.The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance.In vitro characterisation of the fermentation profile and prebiotic capacity of gold-fleshed kiwifruit.Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.Review article: appropriate use of corticosteroids in Crohn's disease.Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians.Management of distal ulcerative colitis: frequently asked questions analysis.Fecal S100A12 in healthy infants and childrenHuman SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.Early postoperative complications have long-term impact on quality of life after restorative proctocolectomy.Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases riskImmunomodulation does not alter histology in resected Crohn's disease.The Asia-Pacific consensus on ulcerative colitis.Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.How IBD patients cope with IBD: a systematic review.Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.Psychotherapy for inflammatory bowel disease: a review and update.Use of exclusive enteral nutrition in adults with Crohn's disease: a review.Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis.Computerised cognitive behavioural therapy for psychological distress in patients with physical illnesses: a systematic review.Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1).Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma.IBD and Environment: Are There Differences between East and West.Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.Does Computerized Cognitive Behavioral Therapy Help People with Inflammatory Bowel Disease? A Randomized Controlled Trial.
P50
Q22251082-0B740C4F-FF73-403F-98B6-15CC5FD0A2A3Q24608662-24106B6C-4C3B-42ED-A47D-29B80459162EQ24618592-0021BDB0-1A1B-4A2A-8629-CD8A4C3E0DC8Q26744329-102AED3A-1420-4D57-B70B-93E7F88A18DDQ26823945-EDB8D0C7-AAD0-471B-B58F-43B3BBF7AF08Q28943305-E7A2EAD6-04F3-4062-9A03-608ABE7C5CCFQ33423258-A0FDCE22-F1DA-4AC1-95C0-365268AF414EQ33458071-CD055868-FFC7-4C5F-BB25-F53EC856E7A7Q34155802-F88EA9D5-597E-4BC6-ADC8-F3999645049BQ34325009-E7D86EF0-68F4-40F5-A188-AA78E1D686A8Q34568904-2DA735C0-DD2E-4A01-9927-2DAF081F8286Q35678108-486E82CC-5072-4D93-A46C-DF143B3E6EDAQ36193147-A33D4DC9-6EA9-47A0-9A2E-3206FF97C397Q36468290-140ECD0E-67A1-4642-82F0-02040E8A9DF1Q36609199-7A13E010-9986-4CC3-9407-7972ACF4B50EQ36884112-9059EEBD-12BC-4A47-A90D-53C68E57E2E2Q37068979-26829D52-3488-468D-893F-3CCC0BBECE35Q37091094-773F628E-3762-4163-A216-F970E05A27EBQ37208681-6B8F3A06-0A19-46A2-A10C-513CAFA564F7Q37215023-3459199C-FCA1-4B08-867F-EF089CD1641AQ37241629-6CDC5396-0A13-4810-BA07-F8E3F23FCA55Q37327893-0F29FF16-FC82-485D-B948-38B0511E56C5Q37335107-926FAB19-BB36-4D9C-9CF2-2486579B0FB2Q37602010-1D8D6912-791B-489B-BEB7-8F69D01BB244Q37725083-FE7D6A86-1954-4FB0-856D-ED8FA3F3DA69Q37799162-84DE1759-62F5-4BF7-A21B-123973EFCC5BQ38020379-9B2EC24E-588F-4D2D-B467-DF648C22145DQ38083493-9A5CD68E-5185-4E02-B503-05A1EB994F7EQ38087144-BB8C9401-CCBC-4FA1-A16B-D383FCB26631Q38166712-C955CB68-836E-4266-AEB4-07E29216E5F6Q38219444-E13793E6-E0B5-4CE1-910C-DA3981E1AF08Q38249777-0D42CC96-5EE7-41AC-B8DD-689D68653C3DQ38349789-B85113E8-C67F-40FE-B87F-5B9F20575CBEQ38394640-C29B322B-7703-48B5-B448-E4C7A5F8FD14Q38394726-69F2964E-D17E-43EB-BE64-B3235FCDF763Q38572827-CF3BEAA9-9C46-4C17-A040-F244909CCAC8Q38741874-A689287D-412A-4732-A9EF-645656218146Q38776731-44192FCF-D615-433E-B79A-E9D10AF45B5FQ38835365-7145DE60-BFCE-42F8-92D0-DA8676C8B0F3Q38965011-6A50F8E0-9F48-4E2D-B221-3E83B1711726
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard B. Gearry
@ast
Richard B. Gearry
@en
Richard B. Gearry
@es
Richard B. Gearry
@nl
Richard B. Gearry
@sl
type
label
Richard B. Gearry
@ast
Richard B. Gearry
@en
Richard B. Gearry
@es
Richard B. Gearry
@nl
Richard B. Gearry
@sl
altLabel
Richard Gearry
@en
prefLabel
Richard B. Gearry
@ast
Richard B. Gearry
@en
Richard B. Gearry
@es
Richard B. Gearry
@nl
Richard B. Gearry
@sl
P106
P1153
6603607435
P21
P31
P496
0000-0002-2298-5141